- Home
- WBS vs TECH Comparison
WBS vs TECH Comparison
Compare WBS & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WBS
- TECH
- Stock Information
- Founded
- WBS 1935
- TECH 1976
- Country
- WBS United States
- TECH United States
- Employees
- WBS N/A
- TECH N/A
- Industry
- WBS Major Banks
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WBS Finance
- TECH Health Care
- Exchange
- WBS Nasdaq
- TECH Nasdaq
- Market Cap
- WBS 9.1B
- TECH 8.0B
- IPO Year
- WBS N/A
- TECH 1989
- Fundamental
- Price
- WBS $45.15
- TECH $48.10
- Analyst Decision
- WBS Buy
- TECH Buy
- Analyst Count
- WBS 14
- TECH 9
- Target Price
- WBS $61.14
- TECH $81.25
- AVG Volume (30 Days)
- WBS 1.6M
- TECH 2.2M
- Earning Date
- WBS 04-24-2025
- TECH 05-07-2025
- Dividend Yield
- WBS 3.54%
- TECH 0.63%
- EPS Growth
- WBS N/A
- TECH N/A
- EPS
- WBS 4.37
- TECH 0.98
- Revenue
- WBS $2,366,786,000.00
- TECH $1,196,016,000.00
- Revenue This Year
- WBS $10.40
- TECH $8.19
- Revenue Next Year
- WBS $6.05
- TECH $8.85
- P/E Ratio
- WBS $10.33
- TECH $49.09
- Revenue Growth
- WBS N/A
- TECH 4.46
- 52 Week Low
- WBS $39.34
- TECH $46.44
- 52 Week High
- WBS $63.99
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- WBS 43.18
- TECH 33.97
- Support Level
- WBS $41.07
- TECH $46.44
- Resistance Level
- WBS $45.24
- TECH $53.00
- Average True Range (ATR)
- WBS 2.71
- TECH 3.30
- MACD
- WBS 0.08
- TECH -0.27
- Stochastic Oscillator
- WBS 46.09
- TECH 13.00
About WBS Webster Financial Corporation
Webster Financial Corp is a full-service provider of financial services, offering commercial and consumer banking, mortgages, and investment advisory along with trust and wealth management services in Connecticut, New York, Rhode Island, Massachusetts, and Pennsylvania. The company's segment includes Commercial Banking, HSA Bank, and Consumer Banking. It generates maximum revenue from the Commercial Banking segment.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.